Advanced Oncotherapy announced that Michel Baelen has joined the Company as Head of Regulatory Affairs and Gerardo d'Auria has been appointed as a new Technical Director with immediate effect. Michel Baelen holds a Doctorate in management sciences from France and is graduated in Electrical Engineering from Belgium. Prior to joining Advanced Oncotherapy, he has held the positions of Health Policy Compliance Director and Head of Regulatory Affairs and Quality Assurance of the proton therapy-based company IBA for over 19 years.

As part of his very strong regulatory background, he has experience in dealing with regulatory authorities in the US and China - two markets of huge relevance to Advanced Oncotherapy as it continues to develop its next generation proton therapy system. Gerardo d'Auria, doctor in physics at the University Federico II of Naples (Italy) has more than 30 years of experience working with RF systems and linear accelerators (Linacs). Senior accelerator scientist at Elettra - Sincrotrone Trieste for over 25 years, prior to joining, as a consultant, Advanced Oncotherapy's team "ADAM" based in Geneva as a Technical Director, he was involved in the design and construction of high power storage ring RF systems and high energy electron Linacs.